Hypera (OTCMKTS:HYPMY) Stock Passes Below 50-Day Moving Average of $8.10
Hypera (OTCMKTS:HYPMY) Stock Passes Below 50-Day Moving Average of $8.10
Hypera S.A. (OTCMKTS:HYPMY – Get Rating)'s share price passed below its fifty day moving average during trading on Thursday . The stock has a fifty day moving average of $8.10 and traded as low as $7.16. Hypera shares last traded at $7.40, with a volume of 2,895 shares trading hands.
在周四的交易中，Hypera S.A.（OTCMKTS: HYPMY — 获取评级）的股价跌破了五十天移动平均线。该股的五十天移动平均线为8.10美元，交易价格低至7.16美元。Hypera股票最后一次交易价格为7.40美元，交易量为2,895股。
Analyst Ratings Changes
分析师评级变化
Separately, Morgan Stanley lowered shares of Hypera from an "overweight" rating to an "equal weight" rating in a research note on Friday, March 10th.
另外，摩根士丹利在3月10日星期五的一份研究报告中将Hypera的股票评级从 “增持” 下调至 “同等权重”。
Hypera Trading Down 1.3 %
Hypera 交易量下跌1.3％
The business's fifty day moving average price is $8.07 and its 200 day moving average price is $8.38.
该公司的五十天移动平均价格为8.07美元，其200天移动平均线价格为8.38美元。
About Hypera
关于 Hypera
(Get Rating)
（获取评分）
Hypera SA operates as a pharmaceutical company in Brazil. It offers prescription products under the Adacne, Addera, apri, AmpliumG, please, Celestamine, Celestone, Celestone Soluspan, Cizax, deciprax, Derive C Micro, Micro Drift, Dermotil Fusid, Digedrat, diprogent, Diprosalic, Diprosone, diprospan, Emprol XR, Flow, Garasone, Halobex, Lipanon, moon, Lydian, macrodantin, MaxSulid, milgamma, Mioflex – A, nesina, Novotram, oximax, peridal, Peridal Suspension, PredSim, pressaliv, Quadriderm, Rizi, Rizi M, softalm, tacroz, tinodin, umma, and velunid brands.
Hypera SA作为一家制药公司在巴西运营。它提供 Adacne、Addera、apri、AmpliumG 下的处方产品，请 Celestamine、Celestone、Celestone Soluspan、Cizax、diciprax、Dirmotil Fusid、Digedrat、diprosalic、diprosone、diprosone、diprosalic、diprosone、diprosone、Diprosan、Emprol XR、Flow、Garasone、Halobex、Librox panon、moon、Lydian、macrodantin、maxSulid、milgamma、Mioflex — A、nesina、Novotram、oximax、predal、pressaliv、Quadridem、Rizi M、softalm、tacroz、tinodin、umma 和 velunid 品牌。
See Also
另见
- Get a free copy of the StockNews.com research report on Hypera (HYPMY)
- MarketBeat Week in Review – 4/3 – 4/7
- Costco Sales Disappoint, Markets Are Missing This Upside Driver
- First Republic Bank Is A Speculative Play, Here's Why
- The WD-40 Company Bottoms With Reversal In Sight
- 3 Low-Cost Stock ETFs That Are Crushing It This Year
- 免费获取 StockNews.com 关于 Hypera (HYPMY) 的研究报告的副本
- MarketBeat 一周回顾 — 4/3 — 4/7
- 好市多的销售令人失望，市场缺少这种上行驱动力
- 第一共和国银行是投机游戏，原因如下
- WD-40 公司触底，逆转在眼前
- 今年有3只低成本股票ETF大放异彩了
Receive News & Ratings for Hypera Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hypera and related companies with MarketBeat.com's FREE daily email newsletter.
接收 Hypera Daily 的新闻和收视率 -在下面输入您的电子邮件地址，通过Marketbeat.com的免费每日电子邮件时事通讯接收Hypera及相关公司最新新闻和分析师评级的简明每日摘要。